Physician

Pierre K Palandjian, D.O.

According to 2025 Medicare claims, Pierre Palandjian, D.O. (NPI: 1174513147) practices ophthalmology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is EYE ASSOCIATES OF LANCASTER LTD (NPI: 1477526424; TIN: 231934764) and primary practice location at 17603-2329.

Palandjian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,511 traditional Medicare patients, billed 4,195 HCPCS/CPT codes, and received $257,285 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,684 prescription claims across 764 beneficiaries totaling $224,326 in drug costs, led by Lumigan (Bimatoprost). 2023 DME data shows 15 claims. Open Payments data shows 7 records totaling $172. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,174	2,963	$251,631
2016	1,220	3,050	$253,434
2017	1,194	3,017	$237,848
2018	1,257	3,039	$268,049
2019	1,262	3,009	$265,331
2020	1,149	2,686	$220,016
2021	1,200	2,839	$225,323
2022	1,234	3,006	$206,425
2023	1,388	3,596	$235,484
2024	1,511	4,195	$257,285

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	443	2,018	$200,577
2016	461	2,140	$225,013
2017	481	2,096	$233,611
2018	521	2,325	$257,414
2019	534	2,215	$222,639
2020	494	2,084	$208,010
2021	522	2,131	$209,253
2022	517	2,080	$196,428
2023	578	2,260	$211,085
2024	764	2,684	$224,326

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	65	65	$4,663
2016	55	55	$3,826
2017	31	31	$1,958
2018	37	37	$2,485
2019	37	48	$3,297
2020	31	31	$1,965
2021	25	25	$1,093
2022	14	14	$587
2023	15	15	$842
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	1,193	1,297	$73
92012	Established patient problem focused exam of visual system	587	992	$54
92083	Exam of visual field with extended testing	342	353	$39
92134	Imaging of retina	295	313	$26
92133	Imaging of optic nerve	398	402	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	91	5,234	$45,923
Restasis	Cyclosporine	21	1,650	$33,944
Cyclosporine	Cyclosporine	20	1,740	$23,727
Latanoprost	Latanoprost	1,070	72,737	$13,136
Brimonidine Tartrate	Brimonidine Tartrate	146	8,486	$11,748

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$172	Dompe US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pierre K. Palandjian, D.O.?

Tedicare shows public-source Medicare data for Pierre K. Palandjian, D.O. (NPI 1174513147), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pierre K. Palandjian, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Pierre K. Palandjian, D.O.?

Pierre K. Palandjian, D.O. is linked to EYE ASSOCIATES OF LANCASTER LTD (billing NPI 1477526424) in the available physician profile data.

Does Pierre K. Palandjian, D.O. have Open Payments data?

Pierre K. Palandjian, D.O. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.